Pfizer Vaccine Should Work Against Omicron, Just Less Efficiently

Pfizer’s CEO, Albert Bourla, believes that the vaccine currently in use for the COVID pandemic should still work with the new Omicron variant, but that it might have less protection. Bourla went on to add that the company would be able to produce a new vaccine within 100 days should it prove...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.